Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Optical Spectroscopy's Diagnosis Accuracy When Non-invasively and Automatically Classifying Skin Lesions in One of the Following Histological Classes: Healthy, Actinic Keratosis, in Situ Carcinoma and Invasive Carcinoma.

NCT02956265 is registered in ClinicalTrials.gov with Centre Hospitalier Régional Metz-Thionville as lead sponsor.

NCT NCT02956265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02956265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Optical Spectroscopy's Diagnosis Accuracy When Non-invasively and Automatically Classifying Skin Lesions in One of the Following Histological Classes: Healthy, Actinic Keratosis, in Situ Carcinoma and Invasive Carcinoma.
Lead sponsor
Centre Hospitalier Régional Metz-Thionville
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2016
Completion date
March 25, 2021
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinomatous or polymorphous skin lesions